✦ LIBER ✦

Immunization against hepatitis B: Report on a WHO meeting on viral hepatitis in Europe

✍ Scribed by Friedrich Deinhardt; Professor Arie J. Zuckerman

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 562 KB
Volume: 17
Category: Article
ISSN: 0146-6615
DOI: 10.1002/jmv.1890170302

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of complete inhibition of viral r

Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection

✍ G Marinos; N V Naoumov; R Williams 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB 👁 2 views

IFN-a and lamivudine, were treated with 16 weeks of 10 megaunits PBMC, peripheral blood mononuclear cell; SI, stimulation index; ALT, alanine transami-of recombinant IFN-a 2b (Intron-A; Schering-Plough, Welwyn Garnase. den City, England) subcutaneously three times a week and 100 mg From the Institu

Hepatitis B vaccine in the prevention of

Hepatitis B vaccine in the prevention of perinatally transmitted hepatitis B virus infection: Final report on a West Midlands pilot study

✍ Dr. Susan M. Wheeley; Elizabeth H. Boxall; Michael J. Tarlow; A. Rashid Gatrad; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

A four-dose vaccination schedule was used to interrupt perinatal transmission of hepatitis B virus from carrier mothers to their babies. Of 49 babies immunised and successfully followed up, 43 (88%) became immune: 15 out of 21 (71%) of babies born to HBeAg + mothers became immune, the other 6 becomi

Report on a single-topic conference on “

Report on a single-topic conference on “Chronic Viral Hepatitis–Strategies to Improve Effectiveness of Screening and Treatment”

✍ John W. Ward; Anna S.F. Lok; David L. Thomas; Hashem B. El-Serag; W. Ray Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

and Roche and has received grants from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Roche, and Merck. David Thomas has been a consultant for Merck and has received grants from Gilead and Merck. Hashem El-Serag has been a consultant for Vertex and has received grants from Bayer and Abbott. Ray Kim

Hepatitis B virus quasispecies in hepati

Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy

✍ Carla S. Coffin; Patricia M. Mulrooney-Cousins; Guido van Marle; John P. Roberts 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

The characterization of hepatitis B virus (HBV) quasispecies in different compartments in liver transplant (LT) recipients may be helpful in optimizing prophylaxis regimens. The aims of this study were to evaluate liver, peripheral blood mononuclear cells (PBMC), and plasma samples for HBV and to co

Chronic ethanol effects on cellular immu

Chronic ethanol effects on cellular immune responses to hepatitis B virus envelope protein: An immunologic mechanism for induction of persistent viral infection in alcoholics

✍ M Geissler; A Gesien; J R Wands 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

## Hepatitis B virus (HBV) is the prototypic member of the Hepatitis B virus (HBV) is common in alcoholics and hepadnavirus family, a group of small, enveloped DNA vimay result in chronic infection. Persistence of HBV infecruses. Members of this family include the woodchuck, tion could be partiall

Effects of transforming growth factor-β1

Effects of transforming growth factor-β1 against the inhibitory action of interferon on DNA synthesis and viral replication in hepatitis B virus DNA-transfected cell

✍ Shinichi Kakumu; Yuji Ito; Takaji Wakita; Kentaro Yoshioka; Tetsuya Ishikawa; Ma 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

## Abstract Studies were undertaken to examine the effects of recombinant human transforming growth factor beta 1 (TGF‐PI) on DNA synthesis and antiviral actions of interferons (IFNs) in HepG2 cell, a hepatoma cell line, transfected with hepatitis B virus (HBV) DNA. The inhibitory effects of IFN‐a